carpall and amelia: ongoing data for car-t in all
Published 5 years ago • 109 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:33
patient selection for car-t in all
-
3:07
the role of bridging and timing in car-t
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
2:08
challenges with car-t therapy in aml & insights into if-better-gated car-t cells
-
1:42
car-t updates in aml and all
-
1:30
insights into nkg2d-targeting car-t cells in r/r aml
-
2:20
car-t assessment in the ambulatory care setting
-
1:28
next steps for car-t in all
-
2:11
future prospects for car-t cell therapy in aml
-
0:44
the future for car t-cells in treating aml
-
9:48
iwal 2019: car-t & cellular therapies in aml and all
-
0:52
the future of car t-cell therapy for aml
-
2:35
what is on the car-t horizon?
-
11:47
what's the latest on car-t in all?
-
1:12
novel all treatment strategies: car t-cells
-
1:10
exciting car-t data in multiple myeloma and follicular lymphoma: cartitude-2, elara & zuma-5
-
2:14
exploring the potential role of cd7-targeting car-t cells for the treatment of t-all
-
1:37
can we target aml with car t-cells?